Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure

NCT00160134 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Congestive Heart Failure

Interventions

DRUG: SLV320

Sponsor

Solvay Pharmaceuticals